000 | 01186 a2200349 4500 | ||
---|---|---|---|
005 | 20250515165322.0 | ||
264 | 0 | _c20090512 | |
008 | 200905s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/j.vaccine.2009.02.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGiezeman, K M | |
245 | 0 | 0 |
_aTrivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity. _h[electronic resource] |
260 |
_bVaccine _cApr 2009 |
||
300 |
_a2414-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aVaccines, Inactivated _xadverse effects |
650 | 0 | 4 |
_aVaccines, Subunit _xadverse effects |
700 | 1 | _aNauta, J | |
700 | 1 | _ade Bruijn, I A | |
700 | 1 | _aPalache, A M | |
773 | 0 |
_tVaccine _gvol. 27 _gno. 18 _gp. 2414-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2009.02.008 _zAvailable from publisher's website |
999 |
_c18800824 _d18800824 |